We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Targeted Nanogels Specifically Transport siRNA into Ovarian Cancer Cells

By LabMedica International staff writers
Posted on 01 Mar 2010
Nanoparticles crafted from hydrogels (nanogels) have been coated with receptor-specific peptides and used to transport siRNA (small, interfering RNA) capable of inhibiting the synthesis of epidermal growth factor receptor (EGFR) into ovarian cancer cells.

Targeted cancer therapy by RNA interference is a relatively new approach that can be used to silence reversibly genes in vivo. More...
In this study, RNA interference technology was used to shut down the gene for EGFR in ovarian cancer cells. Removal of this gene had been shown previously to increase the sensitivity of cancer cells to chemotherapeutic agents.

Delivery of the nucleic acid fragment has been the main hurdle delaying the broad development of siRNA-based therapeutics. In the current study, investigators at the Georgia Institute of Technology (Atlanta, USA) have gotten around this problem by protecting siRNA particles by enclosing them within hydrogel nanoparticles (nanogels). The siRNA was specific for the gene that encodes EGFR, which is highly overexpressed in some types of ovarian cancer. To ensure that the nanogels targeted only cancer cells, they were coated with peptides specific for the EphA2 receptor. Once bound to EphA2 receptors within the cancer cells the particles slowly released the siRNA over a timescale of days, allowing it to have a therapeutic effect.

Results published in the January 11, 2010, online edition of the journal BMC Cancer revealed that treatment of EphA2 positive Hey cells with siRNA-loaded, peptide-targeted nanogels decreased EGFR expression levels and significantly increased the sensitivity of this cell line to docetaxel. Nanogel treatment of SK-OV-3 cells, which are negative for EphA2 expression, failed to reduce EGFR levels and did not increase docetaxel sensitivity.

"With our technique we are inhibiting EGFR's growth, with small interfering RNA. And by inhibiting its growth, we are increasing the cell's apoptotic function. If we hit the cell with chemotherapy at the same time, we should be able to kill the cancer cells more effectively,” said senior author Dr. John McDonald, professor of biology at the Georgia Institute of Technology. "The fact that this system is releasing the siRNA slowly, without giving the cell time to immediately recover, gives us much better efficiency at killing the cancer cells with chemotherapy.”

Related Links:
Georgia Institute of Technology




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
An overview of the study and findings: A) Several brain-derived EVPs cross the blood brain barrier and reach circulation. B) Different EVPs enrich different RNA cargo B) The EVP-RNA is impacted, upregulated (green) or downregulated (red) in AD (Gonzalez-Kozlova, E., et al., Nature Communications (2026). doi.org/10.1038/s41467-026-74541-8)

RNA Blood Test May Enable Earlier Alzheimer’s Disease Diagnosis

Alzheimer’s disease affects an estimated 55 million people worldwide and remains difficult to diagnose at an early stage. Diagnostic workups can be complicated by symptom overlap with other conditions,... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.